[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of inhaled HTPEP-001 in healthy subjects
主要目的:
评价在健康受试者中单次给予吸入用HTPEP-001后的安全性、耐受性。
次要目的:
1.评价在健康受试者中单次给予吸入用HTPEP-001后的药代动力学特征;
2.评价在健康受试者中单次给予吸入用HTPEP-001的免疫原性。
[Translation] Primary objective:
To evaluate the safety and tolerability of HTPEP-001 after a single inhalation in healthy subjects.
Secondary objectives:
1. To evaluate the pharmacokinetic characteristics of HTPEP-001 after a single inhalation in healthy subjects;
2. To evaluate the immunogenicity of HTPEP-001 after a single inhalation in healthy subjects.